Skip to main content
Premium Trial:

Request an Annual Quote

Alveo Technologies Raises $38M in Series A Financing

NEW YORK (GenomeWeb) – Alveo Technologies, a pre-clinical stage medical diagnostics firm, announced today that it has raised $38 million in Series A financing.

The Alameda, California-based startup, which was founded in 2014, said it plans to use the funding to advance the optimization and commercialization of its rapid diagnostic platform for infectious diseases. The firm's technology combines nucleic acid detection with molecular biochemistry in order to identify such illnesses.

Alveo said its Series A funding round, which was led by Maxim Merchant Capital, was oversubscribed, and included existing and new investors.

According to the firm, its platform combines sample prep, genetic material amplification, and real-time detection in a single isothermal microfluidic channel. With a single sample, the platform can multiplex at least 100 tests at once.

"This funding accelerates our vision to provide lifesaving medical information to those who need it, at the most critical times, with technology that is flexible, inexpensive, and accessible worldwide," Alveo Founder and CEO Ron Chiarello said in a statement.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.